Titre:
  • Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
Auteur:Gigante, Elia; Hobeika, Christian; Le Bail, Brigitte; Paradis, Valérie; Tougeron, David; Lequoy, Marie; Bouattour, Mohamed; Blanc, Jean Frédéric; Ganne-Carrié, Nathalie; Tran, Henri; Hollande, Clémence; Allaire, Manon; Amaddeo, Giuliana; Regnault, Hélène; Vigneron, Paul; Ronot, Maxime; Elkrief, Laure; Verset, Gontran; Trepo, Eric; Zaanan, Aziz; Ziol, Marianne; Ningarhari, Massih; Calderaro, Julien; Edeline, Julien; Nault, Jean Charles
Informations sur la publication:Liver Cancer, 11, 5, page (460-473)
Statut de publication:Publié, 2022-09
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Cholangiocarcinoma
Hepatocellular carcinoma
Hepatocholangiocarcinoma
Platinum
Systemic treatment
Tyrosine kinase inhibitors
Langue:Anglais
Identificateurs:urn:issn:1664-5553
info:doi/10.1159/000525488
info:pii/lic-0011-0460
info:pmid/36158591
PMC9485952